Skip to main content
OpenTrials
Completed

NCT Number: NCT02660723

Impact of Aging on Cytokine Production by Innate Immune Cells

The main goal of this study is to investigate the impact of aging on the responsiveness of peripheral blood immune cells. To this aim, the investigators will take advantage of a recently described syringe-based assay system that can reproducibly assess induced, innate or adaptive immune responses. Briefly, a total of 50 healthy volunteers will participate to this study: 25 will be older than 18 and younger than 30, and 25 will be older than 55. A total of 14 ml of blood will be drawn including 5 X 1 ml in TruCulture™ tubes containing poly(I:C), R-848, LPS, CpG, or no stimulus, respectively. After 22 hours of incubation at 37°C, cellular supernatants will assessed for levels of 10 different chemokines using a MesoScaleDiscovery multiplexing platform.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU de Nice, CRC, Hôpital de l'Archet 151 route de saint-antoine de ginestière

Nice, Alpes-Maritimes, 06200, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • volunteers will be invited to settle an appointment with the Nice University Hospital (CHU de Nice) Research Clinical Center (CRC).
  • being between 18 and 30 year-old (group Y) or being older than 55 year-old (group O),
  • ability to understand and speak French,
  • being registered at the Social Security,
  • acceptance to be serologically tested for HIV and HVC,
  • considered healthy based on both past medical records and the clinical examination performed at the inclusion visit,
  • exhibiting a body mass index (body mass divided by the square of their height) comprised between 18.5 and 30.0 kg/m2.

Exclusion criteria

  • having participated to a drug clinical trial since less than 3 months,
  • having traveled to a tropical or a sub-tropical country over the past 3 months,
  • being pregnant or a lactating mother (for women),
  • having performed intensive physical exercise over the past 12 hours,
  • following a specific diet for medical reasons,
  • over-drinking, i.e. more that 50 g of pure alcohol every day,
  • having taken an immuno-suppressive or immuno-modulatory drug over the past two weeks, or for at least 14 consecutive days over the past 6 months,
  • having been vaccinated over the past 3 months,
  • declaring not being on an empty stomach for less than 12 hours,
  • having received a blood transfusion or intravenous immunoglobulins over the past 3 months,
  • declaring being HIV- or HVC- positive,
  • having suffered from an infection since less than 3 weeks,
  • exhibiting a positive urine pregnancy test at the inclusion visit,
  • suffering from a severe/chronic/relapsing pathology, i.e. inflammatory bowel disease, psoriasis, atopic dermatitis, rheumatoid arthritis, multiple sclerosis, type I or type II diabetes, Parkinson's disease, and (p) having been diagnosed with a cancer and not being in a remitting period for less than 5 years.

Treatment and study plan

Healthy Volunteers

Other

A catheter will be introduced in the arm vein and 14 ml of blood will be drawn in one 4 ml dry tube, one 5 ml heparinized tube for cell count and 5 1 ml TruCulture tubes.

Other names: blood test

Primary outcomes

  1. CCL2 levels

    Time frame: at first day

    Compare CCL2 levels in the supernatants of poly(I :C)-stimulated whole blood cells between volunteers aged from 18 to 30 years and volunteers older than 55

Secondary outcomes

  1. Other CCL levels

    Time frame: at first day

    Compare CXCL8 (IL-8) levels in the supernatants of poly(I :C)-stimulated whole blood cells between volunteers aged from 18 to 30 years and volunteers older than 55

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nice

Other

Registry information

Official study title

To Investigate the Impact of Aging on Cytokine and Chemokine Production by Peripheral Blood Immune Cells

Acronym: Cytokinage

Important dates

Study start
2016
Primary completion
2017
Study completion
2018
First posted
Jan 21, 2016
Registry last updated
Jul 23, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.